The agency has approved a Serono will launch the product this summer. In a separate action, the FDA approved the marketing of Gonal-F for treatment of male infertility related to hormone deficiency, making Gonal-F the first recombinant gonadotropin to be approved for treatment of male infertility in the US. More than six million American couples suffer from infertility, cases of which are fairly equally distributed between men and women. The most common cause of infertility in women is anovulation, which is brought about by irregularities in the hormones needed to produce and release healthy eggs. Male infertility may be caused by a number of factors, including hormonal dependent problems with sperm production.
Gonal-F (follitropin alfa)
FDA Approves Gonal-F (Follitropin Alfa) for Male and Female Infertility | DocGuide
All medicines have risks and benefits. Your doctor has weighed the risks of you using GONAL-f against the benefits it is expected to have for you. GONAL-f belongs to a class of hormones called gonadotrophins. FSH is necessary for the growth and development of egg cells follicles in women, and sperm production in men. In women GONAL-f can be used to bring about the development of follicles in women who are not ovulating and who have not responded to treatment with clomiphene citrate. Your doctor may have prescribed it for another reason.
Consumer medicine information
Gonal-F injection contains the active ingredient follitropin alfa, which is synthetic version of a natural sex hormone called follicle stimulating hormone FSH. It is used in the treatment of infertility. In the ovaries in women, FSH increases the number of growing follicles and stimulates their development. Within the follicles are the developing eggs. FSH also increases the production of oestrogen, and under the influence of this hormone, the largest follicle continues to develop.